search icon
clgn-img

Collplant Biotechnologies Ltd, Common Stock

CLGN

NMQ

$3.8439

-$0.08

(-2.04%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$44.03M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.48K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.48
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.24 L
$6.75 H
$3.8439

About Collplant Biotechnologies Ltd, Common Stock

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCLGNSectorS&P500
1-Week Return-14.05%0.31%-1.26%
1-Month Return6.08%0.6%-4.16%
3-Month Return-17.62%-9.44%-0.46%
6-Month Return-24.03%-5.15%3.58%
1-Year Return-33.15%0.33%22.47%
3-Year Return-67.17%4.53%25.13%
5-Year Return-63.39%35.98%77.7%
10-Year Return-79.18%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue2.32M6.14M15.64M299.00K10.96M[{"date":"2019-12-31","value":14.82,"profit":true},{"date":"2020-12-31","value":39.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":1.91,"profit":true},{"date":"2023-12-31","value":70.07,"profit":true}]
Cost of Revenue1.88M3.00M2.00M400.00K1.99M[{"date":"2019-12-31","value":62.59,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":66.79,"profit":true},{"date":"2022-12-31","value":13.32,"profit":true},{"date":"2023-12-31","value":66.32,"profit":true}]
Gross Profit439.00K3.13M13.64M(101.00K)8.97M[{"date":"2019-12-31","value":3.22,"profit":true},{"date":"2020-12-31","value":22.99,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.74,"profit":false},{"date":"2023-12-31","value":65.77,"profit":true}]
Gross Margin18.94%51.08%87.18%(33.78%)81.83%[{"date":"2019-12-31","value":21.72,"profit":true},{"date":"2020-12-31","value":58.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-38.75,"profit":false},{"date":"2023-12-31","value":93.86,"profit":true}]
Operating Expenses8.07M8.73M13.57M17.00M16.48M[{"date":"2019-12-31","value":47.48,"profit":true},{"date":"2020-12-31","value":51.39,"profit":true},{"date":"2021-12-31","value":79.85,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.96,"profit":true}]
Operating Income(7.63M)(5.60M)65.00K(17.10M)(7.51M)[{"date":"2019-12-31","value":-11740,"profit":false},{"date":"2020-12-31","value":-8613.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26303.08,"profit":false},{"date":"2023-12-31","value":-11556.92,"profit":false}]
Total Non-Operating Income/Expense(3.61M)(169.00K)354.00K344.00K997.00K[{"date":"2019-12-31","value":-361.69,"profit":false},{"date":"2020-12-31","value":-16.95,"profit":false},{"date":"2021-12-31","value":35.51,"profit":true},{"date":"2022-12-31","value":34.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(11.16M)(5.77M)237.00K(16.93M)(7.02M)[{"date":"2019-12-31","value":-4710.55,"profit":false},{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2961.6,"profit":false}]
Income Taxes3.53M34.00K(172.00K)(172.00K)(1.00)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.96,"profit":true},{"date":"2021-12-31","value":-4.87,"profit":false},{"date":"2022-12-31","value":-4.87,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(14.70M)(5.81M)409.00K(16.75M)(7.02M)[{"date":"2019-12-31","value":-3593.4,"profit":false},{"date":"2020-12-31","value":-1420.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4096.09,"profit":false},{"date":"2023-12-31","value":-1716.14,"profit":false}]
Income From Continuous Operations(11.16M)(5.77M)237.00K(16.93M)(6.73M)[{"date":"2019-12-31","value":-4710.55,"profit":false},{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2840.08,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.70M)(5.81M)409.00K(16.75M)(7.02M)[{"date":"2019-12-31","value":-3593.4,"profit":false},{"date":"2020-12-31","value":-1420.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4096.09,"profit":false},{"date":"2023-12-31","value":-1716.14,"profit":false}]
EPS (Diluted)(2.46)(0.79)(0.01)(1.53)(0.46)[{"date":"2019-12-31","value":-246.45,"profit":false},{"date":"2020-12-31","value":-79,"profit":false},{"date":"2021-12-31","value":-1,"profit":false},{"date":"2022-12-31","value":-153,"profit":false},{"date":"2023-12-31","value":-46,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CLGN
Cash Ratio 5.01
Current Ratio 5.38
Quick Ratio 5.23

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CLGN
ROA (LTM) -33.77%
ROE (LTM) -61.55%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CLGN
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CLGN
Trailing PE NM
Forward PE 15.55
P/S (TTM) 63.90
P/B 2.66
Price/FCF NM
EV/R 50.58
EV/Ebitda NM

FAQs

What is Collplant Biotechnologies Ltd share price today?

Collplant Biotechnologies Ltd (CLGN) share price today is $3.8439

Can Indians buy Collplant Biotechnologies Ltd shares?

Yes, Indians can buy shares of Collplant Biotechnologies Ltd (CLGN) on Vested. To buy Collplant Biotechnologies Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Collplant Biotechnologies Ltd be purchased?

Yes, you can purchase fractional shares of Collplant Biotechnologies Ltd (CLGN) via the Vested app. You can start investing in Collplant Biotechnologies Ltd (CLGN) with a minimum investment of $1.

How to invest in Collplant Biotechnologies Ltd shares from India?

You can invest in shares of Collplant Biotechnologies Ltd (CLGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in CLGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Collplant Biotechnologies Ltd shares
What is Collplant Biotechnologies Ltd 52-week high and low stock price?

The 52-week high price of Collplant Biotechnologies Ltd (CLGN) is $6.75. The 52-week low price of Collplant Biotechnologies Ltd (CLGN) is $3.24.

What is Collplant Biotechnologies Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Collplant Biotechnologies Ltd (CLGN) is

What is Collplant Biotechnologies Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Collplant Biotechnologies Ltd (CLGN) is 2.66

What is Collplant Biotechnologies Ltd dividend yield?

The dividend yield of Collplant Biotechnologies Ltd (CLGN) is 0.00%

What is the Market Cap of Collplant Biotechnologies Ltd?

The market capitalization of Collplant Biotechnologies Ltd (CLGN) is $44.03M

What is Collplant Biotechnologies Ltd’s stock symbol?

The stock symbol (or ticker) of Collplant Biotechnologies Ltd is CLGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top